M&A Deal Summary

Solvias Acquires Cergentis

On July 12, 2022, Solvias acquired life science company Cergentis

Acquisition Highlights
  • This is Solvias’ 1st transaction in the Life Science sector.
  • This is Solvias’ 1st transaction in the Netherlands.

M&A Deal Summary

Date 2022-07-12
Target Cergentis
Sector Life Science
Buyer(s) Solvias
Deal Type Add-on Acquisition

Target

Cergentis

Utrecht, Netherlands
Cergentis is a genomics-focused biotechnology company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading biopharmaceutical companies and renowned research institutes. Cergentis was founded in 2012 and is based in Utrecht, Netherlands.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Solvias

Kaiseraugst, Switzerland

Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Solvias is contract research, development, and manufacturing. The industries the company serves include pharmaceuticals, biotech, medical device, and cosmetics. Solvias was founded in 1999 and is based in Kaiseraugst, Switzerland.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Netherlands M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-17 Chemic

Canton, Massachusetts, United States

Chemic is a global contract analytical and outsourcing partner to the pharmaceutical, medical device, and biotech industries. Chemic provides a wide array of analytical and manufacturing resources. Chemic was founded in 1998 and is based in Canton, Massachusetts.

Buy -